Vivaldi Coelho Rogerio — SEC Form 4 filings
SEC reporting owner CIK 1610381. 10 Form 4 filings on record with FilingPulse; latest filed 2026-09-01.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-06-04 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 2 filings — 8,000 shares, $300,761 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
- Largest priced transaction: sale of 4,477 shares @ $36.08 ($161,530) in Crinetics Pharmaceuticals, Inc., filed 2026-03-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. (CRNX) | Director | 6 | — | 3 legs · 8,000 sh · $300,761 | 14 |
| Viatris Inc (VTRS) | Director | 4 | — | — | 11 |
Form 4 filings — Vivaldi Coelho Rogerio
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-01 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Disposition to issuer (D): 13,300 @ $85 · Disposition to issuer (D): 5,925 @ $85 · Disposition to issuer (D): 35,000 (derivative) @ $56.69 · Disposition to issuer (D): 8,750 (derivative) @ $66.71 · Disposition to issuer (D): 17,500 (derivative) @ $64.68 · Disposition to issuer (D): 12,500 (derivative) @ $40.29 · +2 more | EDGAR |
| 2026-07-07 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $40 | EDGAR |
| 2026-06-22 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 5,925 @ $0 · Grant/award (A): 9,730 (derivative) @ $0 | EDGAR |
| 2026-03-13 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 4,477 @ $36.08 · Sale (S): 523 @ $36.77 | EDGAR |
| 2026-03-10 | 4 | Viatris Inc (VTRS) | Option exercise (M): 23,660 @ $0 · Option exercise (M): 1,175 @ $0 · Option exercise (M): 23,660 (derivative) @ $0 · Option exercise (M): 1,174.49 (derivative) @ $0 · Grant/award (A): 15,890 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 6,900 @ $0 · Grant/award (A): 10,350 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | Viatris Inc (VTRS) | Grant/award (A): 23,660 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Viatris Inc (VTRS) | Option exercise (M): 21,267 @ $0 · Option exercise (M): 424 @ $0 · Option exercise (M): 21,267 (derivative) @ $0 · Option exercise (M): 423.01 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 3,400 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | Viatris Inc (VTRS) | Grant/award (A): 21,267 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1610381 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →